HomeCNTA • NASDAQ
add
Centessa Pharmaceuticals PLC - ADR
Previous close
$11.86
Day range
$11.95 - $12.42
Year range
$8.46 - $19.09
Market cap
1.61B USD
Avg Volume
790.69K
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 15.00M | — |
Operating expense | 45.78M | 26.84% |
Net income | -26.14M | 31.31% |
Net profit margin | -174.23 | — |
Earnings per share | -0.20 | 47.37% |
EBITDA | -30.69M | 14.76% |
Effective tax rate | -5.65% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 424.90M | 84.60% |
Total assets | 527.84M | 60.84% |
Total liabilities | 141.60M | 25.30% |
Total equity | 386.25M | — |
Shares outstanding | 133.03M | — |
Price to book | 4.09 | — |
Return on assets | -13.93% | — |
Return on capital | -15.16% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -26.14M | 31.31% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2020
Website
Employees
77
